Neutrophil peptidylarginine deiminase 4 is essential for detrimental age-related cardiac remodelling and dysfunction in mice
Authors:
- Stijn Van BruggenSBStijn Van Bruggen
- Sirima KraisinSKSirima Kraisin
- Jore Van WauweJWJore Van Wauwe
- Katrien BomhalsKBKatrien Bomhals
- Mathias StroobantsMSMathias Stroobants
- Paolo CaraiPCPaolo Carai
- Alexander Van De BruaeneABAlexander Van De Bruaene
- Thilo WitschTWThilo Witsch
- Kimberly MartinodKMKimberly Martinod
- 2 October 2023
- journal article
- research article
- Published by The Royal Society in Philosophical Transactions of the Royal Society B: Biological Sciences
- Vol. 378 (1890) , 20220475
Abstract
Mice fully deficient in peptidylarginine deiminase 4 (PAD4) enzyme have preserved cardiac function and reduced collagen deposition during ageing. The cellular source of PAD4 is hypothesized to be neutrophils, likely due to PAD4's involvement in neutrophil extracellular trap release. We investigated haematopoietic PAD4 impact on myocardial remodelling and systemic inflammation in cardiac ageing by generating mice with Padi4 deletion in circulating neutrophils under the MRP8 promoter (Ne-PAD4 −/− ), and ageing them for 2 years together with littermate controls (PAD4 fl/fl ). Ne-PAD4 −/− mice showed protection against age-induced fibrosis, seen by reduced cardiac collagen deposition. Echocardiography analysis of structural and functional parameters also demonstrated preservation of both systolic and diastolic function with MRP8-driven PAD4 deletion. Furthermore, cardiac gene expression and plasma cytokine levels were evaluated. Cardiac genes and plasma cytokines involved in neutrophil recruitment were downregulated in aged Ne-PAD4 −/− animals compared to PAD4 fl/fl controls, including decreased levels of C-X-C ligand 1 (CXCL1). Our data confirm PAD4 involvement from circulating neutrophils in detrimental cardiac remodelling, leading to cardiac dysfunction with old age. Deletion of PAD4 in MRP8-expressing cells impacts the CXCL1–CXCR2 axis, known to be involved in heart failure development. This supports the future use of PAD4 inhibitors in cardiovascular disease. This article is part of the Theo Murphy meeting issue ‘The virtues and vices of protein citrullination’.Keywords
Funding Information
- Fonds Wetenschappelijk Onderzoek (G097821N)
- Fonds Wetenschappelijk Onderzoek (G0G1719N)
This publication has 61 references indexed in Scilit:
- Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in miceProceedings of the National Academy of Sciences of the United States of America, 2013
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Age-associated chronic diseases require age-old medicine: Role of chronic inflammationPreventive Medicine, 2012
- Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular trapsJournal of Cell Biology, 2010
- PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular trapsJournal of Experimental Medicine, 2010
- Extracellular DNA traps promote thrombosisProceedings of the National Academy of Sciences, 2010
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Aging of the Immune System: How Much Can the Adaptive Immune System Adapt?Immunity, 2006
- Neutrophil Extracellular Traps Kill BacteriaScience, 2004